ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 48856 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 48856; 2) Community: the network communities that were significantly associated with the response to NSC 48856; 3) Molecule: the relationships between components within communities and NSC 48856; 4) MDR: the compounds that were significantly associated with the NSC 48856.

NSC Compound Enrichment Correlation
NSC 212446 Null 0.04831289866584 0.41385447
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.04831289866584 0.083222897
NSC 237677 Null 0.04831289866584 0.17155717
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.04831289866584 0.23281768
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.04831289866584 -0.090372607
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.04831289866584 0.098537299
NSC 352299 2-methylellpticinium 0.04831289866584 -0.14187164
NSC 357680 BUELLOLIDE 0.04831289866584 0.52047043
NSC 381866 BAFILOMYCIN DERIV. 0.04831289866584 0.32880406
NSC 382770 Null 0.04831289866584 0.17492637
Total:85  Current:82    [First] [Prev] [Next] [Last]